Home/Catalog/Analytical Lifecycle Management Under ICH Q14 and Q2(R2): What Changes Operationally
← Back to Catalog
Live WebinarNew

Analytical Lifecycle Management Under ICH Q14 and Q2(R2): What Changes Operationally

Understand the operational impact of ICH Q14 and Q2(R2) on analytical method development, validation, transfer, and lifecycle management in regulated pharmaceutical environments.

4.8(0 reviews)
90 minutesFriday, August 21, 2026
Meredith Crabtree

Instructor

Meredith Crabtree

GMP Quality Consultant & Validation Specialist

What You'll Learn

Understand the operational impact of ICH Q14 and Q2(R2) on analytical method development and validation strategies
Determine what evidence is sufficient during analytical method development to support lifecycle decisions
Establish method flexibility boundaries without creating regulatory risk
Define analytical control strategies that support ongoing lifecycle management
Determine when method changes require additional validation, justification, or regulatory notification
Manage method transfer challenges across laboratories and sites
Monitor ongoing method performance and detect meaningful performance drift
Build documentation that supports defensible lifecycle decisions during inspections

About This Event

The implementation of ICH Q14 and the revised ICH Q2(R2) guidance is changing how organizations approach analytical method development, validation, transfer, maintenance, and lifecycle management. While many companies understand the principles described within the guidance documents, uncertainty often arises when translating those expectations into practical laboratory, quality, validation, and regulatory activities. This session examines the operational impact of ICH Q14 and Q2(R2) beyond the guidance language itself. The discussion will focus on how analytical lifecycle concepts influence method development decisions, validation strategies, change management activities, continued performance monitoring, and regulatory expectations. Organizations often discover that the greatest challenge is not generating validation data, but explaining why a method was designed a certain way, determining how much flexibility exists when changes become necessary, and deciding what evidence is required to support those changes. Code: FDB1616

Curriculum

From Validation Event to Lifecycle Approach — How ICH Q14 Changes the Paradigm
20 min
Sufficient Evidence During Development — Defining the Boundaries
15 min
Establishing Method Flexibility Without Regulatory Risk
15 min

Requirements

  • Analytical, QC, QA, or regulatory professionals working with pharmaceutical or biotechnology methods
  • Applicable to method development scientists, validation leads, lab managers, regulatory affairs, and CMC technical services personnel

Who Should Attend

Analytical Development Scientists, Quality Control (QC) Departments, Quality Assurance (QA) Departments, Laboratory Managers and Supervisors, Validation and Qualification Professionals, Regulatory Affairs Departments, CMC and Technical Services Personnel, Pharmaceutical and Biotechnology Manufacturing Professionals.

Areas Covered

Determining What Evidence Is Sufficient During Analytical Method Development
Establishing Method Flexibility Without Creating Regulatory Risk
Defining Analytical Control Strategies That Support Lifecycle Management
Determining When Method Changes Require Additional Validation or Justification
Managing Method Transfer Challenges Across Laboratories and Sites
Monitoring Ongoing Method Performance and Detecting Meaningful Drift
Documentation and Evidence Supporting Defensible Lifecycle Decisions
Operational Expectations Under ICH Q14 and Q2(R2) Throughout the Method Lifecycle

Meet Your Instructor

Meredith Crabtree

Meredith Crabtree

GMP Quality Consultant & Validation Specialist

Meredith Crabtree has over 30 years' experience in regulated industries, ranging from Blood, Plasma, Tissue, Laboratory, Pharma, Medical Device, Cosmetics, Supplements, and Animal Health. This includes manufacturing, packaging, labelling and distribution operations. Meredith is the owner of MLKC Consulting and specializes in product label reviews, 3rd party inspections, Consent Decree and Recall support.

30+ Years GMP ExperienceIQ/OQ/PQ SpecialistConsent Decree SupportMulti-Industry QA Expert
Quantity
1

Single Access

$240.00
Buy Now
Secure payment via Stripe
Certificate of completion

Event Details

Format

Live Webinar

Duration

90 minutes

Certificate

Included

Date

Friday, August 21, 2026

Related Events

AI in GMP: What the FDA Is Already Expecting - Before You Ask
Live WebinarNew-24%
Regulatory & ComplianceCertificate

AI in GMP: What the FDA Is Already Expecting - Before You Ask

FDA already expects GMP compliance for AI systems. Learn how existing validation, data integrity, and oversight rules apply—before regulators come calling.

Dr. Ginette CollazoDr. Ginette Collazo
1.5 hoursJun 30, 2026
4.8
$190.00$250.00
View Details
HPLC Analytical Method Development and Validation
Live WebinarNew
Regulatory & ComplianceCertificate

HPLC Analytical Method Development and Validation

Master HPLC instrument and method validation to meet US EPA and FDA requirements for pharmaceutical analysis.

Dr. John C. FetzerDr. John C. Fetzer
1 hourJun 17, 2026
4.8
$145.00
View Details
ChatGPT-Assisted Technical Writing
Live WebinarNew
Regulatory & ComplianceCertificate

ChatGPT-Assisted Technical Writing

Learn practical, compliant approaches to using ChatGPT for SOP drafting, document development, and technical writing in regulated industries.

Charles H. PaulCharles H. Paul
1 hourJun 24, 2026
4.9
$190.00
View Details